Scientific Articles
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study
Yoshiki Mikami, Takayuki Ueno, Kenichi Yoshimura, Hitoshi Tsuda, Masafumi Kurosumi, Shinobu Masuda, Rie Horii, Masakazu Toi and Hironobu Sasano
Cancer Science. 2013 Nov; 104(11): 1539–1543.
https://doi.org/10.1111/cas.12245
An Overview of the Japan Breast Cancer Research Group (JBCRG) activities
Shinji Ohno, Katsumasa Kuroi and Masakazu Toi
Breast Cancer. 2013 Oct; 20(4): 291-5.
https://doi.org/10.1007/s12282-012-0420-8
Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: A multi-institution survey.
Kosuke Kawaguchi, Hiroshi Ishiguro, Satoshi Morita, Seigo Nakamura, Shinji Ohno, Norikazu Masuda, Hiroji Iwata, Kenjiro Aogi, Katsumasa Kuroi, Masakazu Toi; Japan Breast Cancer Research Group (JBCRG)
Breast Cancer Research and Treatment. 2011; 130(2): 627-634.
https://doi.org/10.1007/s10549-011-1641-9
Economic evaluation of the 21-gene signature (Oncotype DX(®)) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03).
Masahide Kondo, Shu-Ling Hoshi, Takeharu,Yamanaka, Hiroshi Ishiguro, Masakazu Toi
Breast Cancer Research and Treatment. 2011 Jun; 127(3): 739-49.
https://doi.org/10.1007/s10549-010-1243-y
Clinical Significance of the 21-Gene Signature (Oncotype DX) in Hormone Receptor-Positive Early Stage Primary Breast Cancer in the Japanese Population
Masakazu Toi, Hiroji Iwata, Takeharu Yamanaka, Norikazu Masuda, Shinji Ohno, Seigo Nakamura, Takahiro Nakayama, Masahiro Kashiwaba, Shunji Kamigaki, Katsumasa Kuroi; and the Japan Breast Cancer Research Group-Translational Research
Cancer.2010 Jul; 116(13): 3112-3118
https://doi.org/10.1002/cncr.25206
by Voluntary Organization JBCRG